CD44 and hepatocellular carcinoma: With respect to the role of DNMT1, the knockdown of non-collagenous bone matrix protein osteopontin in CD133+/CD44+ HCC cells, which have cancer stem cell properties, suppresses DMNT1 expression and promotes HCC metastasis [33].